ZA201002974B - Mcp-i binding nucleic acids and use thereof - Google Patents
Mcp-i binding nucleic acids and use thereofInfo
- Publication number
- ZA201002974B ZA201002974B ZA2010/02974A ZA201002974A ZA201002974B ZA 201002974 B ZA201002974 B ZA 201002974B ZA 2010/02974 A ZA2010/02974 A ZA 2010/02974A ZA 201002974 A ZA201002974 A ZA 201002974A ZA 201002974 B ZA201002974 B ZA 201002974B
- Authority
- ZA
- South Africa
- Prior art keywords
- mcp
- nucleic acids
- binding nucleic
- binding
- acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07023267 | 2007-11-30 | ||
| PCT/EP2008/010167 WO2009068318A1 (en) | 2007-11-30 | 2008-11-29 | Mcp-i binding nucleic acids and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201002974B true ZA201002974B (en) | 2011-07-27 |
Family
ID=40415282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2010/02974A ZA201002974B (en) | 2007-11-30 | 2010-04-29 | Mcp-i binding nucleic acids and use thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20100311816A1 (enExample) |
| EP (1) | EP2229442A1 (enExample) |
| JP (1) | JP5777341B2 (enExample) |
| KR (1) | KR20100092463A (enExample) |
| CN (1) | CN101878305A (enExample) |
| AU (1) | AU2008329070B2 (enExample) |
| BR (1) | BRPI0819845A2 (enExample) |
| CA (1) | CA2707089A1 (enExample) |
| MX (1) | MX2010005916A (enExample) |
| RU (1) | RU2542973C2 (enExample) |
| WO (1) | WO2009068318A1 (enExample) |
| ZA (1) | ZA201002974B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2638847C (en) | 2006-02-14 | 2016-08-09 | Noxxon Pharma Ag | Mcp-1 binding nucleic acids |
| WO2009068318A1 (en) * | 2007-11-30 | 2009-06-04 | Noxxon Pharma Ag | Mcp-i binding nucleic acids and use thereof |
| WO2012025251A1 (en) | 2010-08-27 | 2012-03-01 | Noxxon Pharma Ag | Nucleic acids for treatment of chronic complications of diabetes |
| CN102621331B (zh) * | 2012-04-05 | 2014-07-30 | 中国医学科学院病原生物学研究所 | 一种检测或辅助检测结核性胸膜炎的试剂盒 |
| JP2017502075A (ja) * | 2013-11-04 | 2017-01-19 | ノクソン ファーマ エージー | 腎障害治療の手段および方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6670321B1 (en) * | 1998-12-30 | 2003-12-30 | The Children's Medical Center Corporation | Prevention and treatment for retinal ischemia and edema |
| US20070026394A1 (en) * | 2000-02-11 | 2007-02-01 | Lawrence Blatt | Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies |
| ES2346640T4 (es) * | 2001-10-26 | 2011-04-26 | Noxxon Pharma Ag | Ácido l-nucleico modificado. |
| US7879991B2 (en) * | 2002-05-06 | 2011-02-01 | Noxxon Pharma Ag | CGRP binding nucleic acids |
| AU2003251681A1 (en) * | 2002-08-01 | 2004-02-23 | Noxxon Pharma Ag | Ghrelin binding nucleic acids |
| CA2521950C (en) * | 2003-04-15 | 2009-11-17 | Merck & Co., Inc. | Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| US20060030535A1 (en) * | 2004-03-05 | 2006-02-09 | Healy Judith M | Controlled modulation of the pharmacokinetics and biodistribution of aptamer therapeutics |
| US20060257359A1 (en) * | 2005-02-28 | 2006-11-16 | Cedric Francois | Modifying macrophage phenotype for treatment of disease |
| CA2638847C (en) * | 2006-02-14 | 2016-08-09 | Noxxon Pharma Ag | Mcp-1 binding nucleic acids |
| US8367629B2 (en) * | 2006-02-14 | 2013-02-05 | Noxxon Pharma Ag | MCP-1 binding nucleic acids and use thereof |
| WO2009068318A1 (en) * | 2007-11-30 | 2009-06-04 | Noxxon Pharma Ag | Mcp-i binding nucleic acids and use thereof |
-
2008
- 2008-11-29 WO PCT/EP2008/010167 patent/WO2009068318A1/en not_active Ceased
- 2008-11-29 BR BRPI0819845-4A patent/BRPI0819845A2/pt active Search and Examination
- 2008-11-29 AU AU2008329070A patent/AU2008329070B2/en not_active Ceased
- 2008-11-29 CN CN2008801184556A patent/CN101878305A/zh active Pending
- 2008-11-29 CA CA2707089A patent/CA2707089A1/en not_active Abandoned
- 2008-11-29 US US12/745,545 patent/US20100311816A1/en not_active Abandoned
- 2008-11-29 RU RU2010126662/10A patent/RU2542973C2/ru not_active IP Right Cessation
- 2008-11-29 JP JP2010535301A patent/JP5777341B2/ja not_active Expired - Fee Related
- 2008-11-29 KR KR1020107011757A patent/KR20100092463A/ko not_active Ceased
- 2008-11-29 EP EP08855575A patent/EP2229442A1/en not_active Withdrawn
- 2008-11-29 MX MX2010005916A patent/MX2010005916A/es active IP Right Grant
-
2010
- 2010-04-29 ZA ZA2010/02974A patent/ZA201002974B/en unknown
-
2014
- 2014-05-15 US US14/277,826 patent/US20150141496A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009068318A1 (en) | 2009-06-04 |
| RU2010126662A (ru) | 2012-01-10 |
| JP5777341B2 (ja) | 2015-09-09 |
| CN101878305A (zh) | 2010-11-03 |
| RU2542973C2 (ru) | 2015-02-27 |
| US20150141496A1 (en) | 2015-05-21 |
| AU2008329070B2 (en) | 2014-11-20 |
| AU2008329070A1 (en) | 2009-06-04 |
| JP2011504736A (ja) | 2011-02-17 |
| CA2707089A1 (en) | 2009-06-04 |
| BRPI0819845A2 (pt) | 2015-06-16 |
| KR20100092463A (ko) | 2010-08-20 |
| US20100311816A1 (en) | 2010-12-09 |
| MX2010005916A (es) | 2010-06-11 |
| EP2229442A1 (en) | 2010-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2211904T (pt) | Agentes de ligação a cd19 e seus usos | |
| IL206356A0 (en) | Improved fibronectin-based binding molecules and their use | |
| GB0706243D0 (en) | Modified nucleic acids | |
| SG10201600632QA (en) | Sdf-1 binding nucleic acids and the use thereof | |
| PT2274331E (pt) | Moléculas de ligação baseadas em fibronectina melhoradas e suas utilizações | |
| GB0621973D0 (en) | Binding molecules and uses thereof | |
| EP2262840A4 (en) | METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINS | |
| GB2449354B (en) | Binding protein | |
| SG10201801945TA (en) | Specific binding proteins and uses thereof | |
| IL186085A0 (en) | Ghrelin binding nucleic acids | |
| PL2041282T3 (pl) | Kwasy nukleinowe wiążące sdf-i | |
| GB2462374B (en) | Phosphate binding materials and their uses | |
| ZA201002974B (en) | Mcp-i binding nucleic acids and use thereof | |
| GB0706631D0 (en) | Nucleic acids and libraries | |
| GB0724832D0 (en) | Proteins and nucleic acids | |
| GB0720675D0 (en) | Oligonucleotides and uses thereof | |
| GB0819666D0 (en) | Microarray and use thereof | |
| GB0602718D0 (en) | Nucleic Acid Manipulation | |
| GB0625165D0 (en) | Novel binding agents and uses thereof | |
| GB0815113D0 (en) | Oligonucleotides and uses thereof | |
| GB0714997D0 (en) | Binding surfaces |